First In-Vivo Gene-Editing Therapy Successfully Saves Newborn's Life in 2025
By
QueensGambit
The kind of bagel that ruins lesser bagels for you.
Summary
In 2025, doctors and scientists in the U.S. successfully performed the world's first custom gene-editing therapy inside a living person—a newborn with a genetic disorder who otherwise faced a grim prognosis. This breakthrough marks a historic moment in medicine, as gene editing was used to save the infant's life by correcting a genetic defect directly within the body, rather than editing cells outside the body and reintroducing them.
Key quotes
· 3 pulledFor all of human history, a person born with such a disorder likely had to live with the condition, and depending on the defect, those lives could be brutally short.
But in 2025, human history changed
Life's ability to successfully copy three billion distinct letters in the human genome is an absolute biological wonder—but sometimes, mistakes are made.
You might also wanna read
Single Infusion of Gene-Editing Therapy VERVE-102 Shows Promise for Inherited High Cholesterol
An experimental gene-editing therapy called VERVE-102, developed by Verve Therapeutics (a subsidiary of Eli Lilly), shows promise in treatin
discovermagazine.com·2d ago
Eli Lilly's experimental gene-editing therapy VERVE-102 shows promise as one-time treatment for high cholesterol
Eli Lilly is testing VERVE-102, an experimental gene-editing therapy for high cholesterol that could be administered as a one-time infusion
abcnews.com·2d ago